The Psychedelic Practitioner Issue 2: Preparation Post published:December 11, 2025 Post category:News/The Psychedelic Practitioner
Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next Post published:December 10, 2025 Post category:Interviews/Pα+
The Psychedelic News Feed: December 1 – 7, 2025 Post published:December 9, 2025 Post category:Psychedelic News Feed Archive
Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout Plans Post published:December 5, 2025 Post category:Psychedelic Bulletin/Pα+
The View from D.C.: Psychedelic Politics, Blockers and Approvals on the Horizon Post published:December 3, 2025 Post category:Analysis/News/Pα+
The Psychedelic News Feed: November 24 – 30, 2025 Post published:December 1, 2025 Post category:Psychedelic News Feed Archive
Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and Competition Post published:November 26, 2025 Post category:Interviews/Pα+
The Psychedelic News Feed: November 17 – 23, 2025 Post published:November 24, 2025 Post category:Psychedelic News Feed Archive
ARPA-H Launches $100M Effort to “Demystify” Mental Health and Catalyse Rapid-Acting Behavioural Health Therapeutics, Including Psychedelics Post published:November 22, 2025 Post category:Analysis/News/Pα+
Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b Debrief; UK Government Responds to MPs’ Psilocybin-Related Questions Post published:November 19, 2025 Post category:Psychedelic Bulletin/Pα+